Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy

Prostate Cancer and Prostatic Diseases volume 9, pages 370–373 (2006)Cite this article

Abstract

In men with locally advanced/high-risk prostate cancer, there is an ongoing challenge to achieve improved results. Dose escalation studies using three-dimensional conformal radiotherapy (3D-CRT) or intensity modulated radiation therapy (IMRT) have shown benefit particularly in the intermediate and poor risk groups of patients. Of concern, however, is the increase in documented rectal toxicity. High-dose rate brachytherapy (HDR-BT) as a boost in combination with external beam radiotherapy (EBRT) is an alternative strategy of dose escalation that can potentially achieve an even higher biological equivalent dose (BED) to the tumour. The results so far are very encouraging for men with poor prognosis disease. Moreover the technique is associated with very low rates of acute and late toxicity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Article 23 September 2019

Nadia Harbeck, Frédérique Penault-Llorca, … Fatima Cardoso

References

  1. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969–974.

    Article  CAS  Google Scholar 

  2. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2005; 92: 488–498.

    Article  CAS  Google Scholar 

  3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001; 166: 876–881.

    Article  CAS  Google Scholar 

  4. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097–1105.

    Article  Google Scholar 

  5. Bentzen SM, Ritter MA . The alpha/beta ratio for prostate cancer: what is it, really? Radiother Oncol 2005; 76: 1–3.

    Article  Google Scholar 

  6. Kim Y, Hsu IC, Lessard E, Vujic J, Pouliot J . Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions. Int J Radiat Oncol Biol Phys 2004; 59: 1208–1216.

    Article  Google Scholar 

  7. Hoskin PJ, Bownes PJ, Ostler P, Walker K, Bryant L . High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions. Radiother Oncol 2003; 68: 285–288.

    Article  Google Scholar 

  8. Galalae RM, Martinez A, Mate T, Mitchell C, Edmundson G, Nuernberg N et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 1048–1055.

    Article  Google Scholar 

  9. Martin T, Roddiger S, Kurek R, Dannenberg T, Eckart O, Kolotas C et al. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer. Radiother Oncol 2004; 71: 35–41.

    Article  Google Scholar 

  10. Pellizzon AC, Nadalin W, Salvajoli JV, Fogaroli RC, Novaes PE, Maia MA et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer. Radiother Oncol 2003; 66: 167–172.

    Article  Google Scholar 

  11. Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y . Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 59: 684–690.

    Article  Google Scholar 

  12. Morton GC . The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol (R Coll Radiol) 2005; 17: 219–227.

    Article  CAS  Google Scholar 

  13. Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L . High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys 1998; 41: 525–533.

    Article  CAS  Google Scholar 

  14. Martinez AA, Gustafson G, Gonzalez J, Armour E, Mitchell C, Edmundson G et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer. Int J Radiat Oncol Biol Phys 2002; 53: 316–327.

    Article  Google Scholar 

  15. Galalae RM, Kovacs G, Schultze J, Loch T, Rzehak P, Wilhelm R et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2002; 52: 81–90.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, University College London Hospital, London, UK

    O Al-Salihi, A Mitra & H Payne

Authors
  1. O Al-Salihi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Mitra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H Payne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O Al-Salihi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al-Salihi, O., Mitra, A. & Payne, H. Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy. Prostate Cancer Prostatic Dis 9, 370–373 (2006). https://doi.org/10.1038/sj.pcan.4500893

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500893

Keywords

This article is cited by

Search

Advanced search

Quick links